| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/24/2003 | US20030138914 Factor X deletion mutants and analogues thereof |
| 07/24/2003 | US20030138910 Incubating blood for in vitro (syringe) induction of modulators to cytokine binding membrane protein; antiarthritic agents |
| 07/24/2003 | US20030138907 Preparing and recovering a genetically engineered muscle protein by protecting sulfhydryl groups (reaction with sodium tetrathionate) and isolation by anion exchange chromatography and hydrophobic interaction chromatography |
| 07/24/2003 | US20030138905 Compositions isolated from bovine mammary gland and methods for their use |
| 07/24/2003 | US20030138896 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138894 Angiotensin converting enzyme-2/like polypeptides and inhibitors for treating and/or prevention of hypertension, congestive heart failure, stroke and atherosclerotic heart disease |
| 07/24/2003 | US20030138893 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138892 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138891 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138890 Anticarcinogenic/antitumor/antiarthritic/antiinflammatory agents; analgesics; angiogenesis inhibitors; gene expression inhibition |
| 07/24/2003 | US20030138889 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138888 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138887 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 07/24/2003 | US20030138886 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138885 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138884 APRIL- a novel protein with growth effects |
| 07/24/2003 | US20030138883 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 07/24/2003 | US20030138882 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138881 Novel co-stimulatory molecules |
| 07/24/2003 | US20030138879 Phosphopantetheinyl transferases and uses thereof |
| 07/24/2003 | US20030138865 Incubating LN3 cells expressing Peripheral-type benzodiazepine receptors (PBR)/(HRPC) with antitumor agents and monitoring tumor progression; antisense therapy; drug screening; antiandrogens |
| 07/24/2003 | US20030138864 Comparing expression levels of genes or proteins in human tissue or cells from normal and tumor origin, selecting enzyme of which mRNA or protein levels in tumor tissue are higher by two-fold as compared to normal cells or tissue |
| 07/24/2003 | US20030138854 Method for determining BAGE expression |
| 07/24/2003 | US20030138848 3D structure of polypeptides containing a TPR-structure motif with chaperone-binding function, crystals thereof and compounds for inhibition of said polypeptides |
| 07/24/2003 | US20030138839 Polypeptide comprising ubiquitination regulating domain; antiproliferative agents; neuroprotectants; cancer diagnosis |
| 07/24/2003 | US20030138835 Tumor suppressors |
| 07/24/2003 | US20030138826 Compositions, methods, and kits relating to resistin-like molecules |
| 07/24/2003 | US20030138818 G-protein coupled receptors |
| 07/24/2003 | US20030138808 Polypeptides wherein epitopes correspond to proteosome cleavage product of tyrosinase and major histocompatability complex; vaccine |
| 07/24/2003 | US20030138804 Hemagglutinin binding protein; antiallergens; antinflammatory; neuroprotectants; wound healing agents |
| 07/24/2003 | US20030138803 Identification and use of molecules implicated in pain |
| 07/24/2003 | US20030138799 Monitoring morphological adjustment in cell structure of tissue transfected with cancer gene; gut-enriched kruppel-like factor/epithelial zinc finger (GKLF); side effect reduction; antitumor/antiproliferative agents |
| 07/24/2003 | US20030138795 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, BGS-8, expressed highly in immune tissue |
| 07/24/2003 | US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy |
| 07/24/2003 | US20030138771 Detecting target (open reading frames) of bactericides/microbiocides; immunoaffinity chromatography/immunoprecipitation assay |
| 07/24/2003 | US20030138502 Method for protecting human skin |
| 07/24/2003 | US20030138491 Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins |
| 07/24/2003 | US20030138488 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 07/24/2003 | US20030138483 The filler contains an alcohol to dissolve the drug and maintain in solution; treating human immunodeficiency virus infections |
| 07/24/2003 | US20030138476 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 07/24/2003 | US20030138460 For immobilizing an animal for treatment by administration of botulinum toxin serotype and a polysaccharide stabilizer; veterinary medicine |
| 07/24/2003 | US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery |
| 07/24/2003 | US20030138449 Method of administering FimH protein as a vaccine for urinary tract infections |
| 07/24/2003 | US20030138444 Composition and method for treating HIV infection |
| 07/24/2003 | US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome |
| 07/24/2003 | US20030138441 A polynucleotide sequence which encodes a Dermatophagoides dust mite protein, wherein the codon usage pattern of the polynucleotide sequence resembles that of highly expressed mammalian genes |
| 07/24/2003 | US20030138440 Multimeric proteins and methods of making and using same |
| 07/24/2003 | US20030138439 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to above polypeptides; |
| 07/24/2003 | US20030138438 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/24/2003 | US20030138437 Botulinum toxin and a polysaccharide, such as a hydroxyethyl starch, free of any blood or serum derived proteins, filtrates or fractions useful for diagnostic, therapeutic and/ or research |
| 07/24/2003 | US20030138429 Compositions and methods for inhibiting metastasis |
| 07/24/2003 | US20030138428 In vitro and in vivo diagnosis, immunization, and therapy of neoplastic tumors, particularly carcinomas, by means of specifically targeted analogue peptides containing amino acid sequences encompassing CDRs of different species |
| 07/24/2003 | US20030138427 Enzyme inhibition of HLE by an antagonist to interrupt plasma events, e.g., HIV, bacterial infections, autoimmune diseases) by interacting with each of the catalytic triad of the HLE plasma membranes protein; antiinflammatory agents |
| 07/24/2003 | US20030138426 Human tumor necrosis factor receptor-like proteins TR11, TR11SV1, and TR11SV2 |
| 07/24/2003 | US20030138424 An antibody capable of inhibiting the binding between parathyroid hormone related protein (PTHrP) and a receptor; antagonists; systemic disorders caused by cancer; anorexic agents; anemia, electrolyte imbalance; immunotherapy |
| 07/24/2003 | US20030138420 Administering a tissue factor, e.g., a monoclonal antibody, a human tissue factor binding site polypeptide analog of <50 amino acid residues, by injection into the tissue of the central nervous system, brain and myocardium; anticoagulants |
| 07/24/2003 | US20030138418 Encoding GAVE18, a heretofore unknown G- protein-coupled receptor, involved in cellular signal transduction; antiinflammatory agents; hypotensive agents; antiarrhymia agents; bronchodilation agents; glandular disorders; |
| 07/24/2003 | US20030138416 Use of glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes |
| 07/24/2003 | US20030138414 Modulators of methylation for control of bacterial virulence |
| 07/24/2003 | US20030138410 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 07/24/2003 | US20030138407 Therapeutic methods for nucleic acid delivery vehicles |
| 07/24/2003 | US20030138404 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/24/2003 | US20030138403 Interferon formulations |
| 07/24/2003 | US20030138401 Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders |
| 07/24/2003 | US20030138400 Polypeptides that are truncated forms of human chemokine beta-8 |
| 07/24/2003 | US20030138399 Anti-inflammatory therapy for inflammatory mediated infection |
| 07/24/2003 | US20030138397 Anionic polymers as toxin binders and antibacterial agents |
| 07/24/2003 | CA2841097A1 Albumin fusion proteins |
| 07/24/2003 | CA2680946A1 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 07/24/2003 | CA2513013A1 Use of soluble .gamma..delta. t cell receptors for regulating t cell function |
| 07/24/2003 | CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | CA2475993A1 Defective entities and uses therefor |
| 07/24/2003 | CA2474141A1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | CA2473570A1 Antisense compounds directed against human csf-1 |
| 07/24/2003 | CA2473447A1 Solid salts of benzazepine compounds and their use in the preparation of pharmaceutical compounds |
| 07/24/2003 | CA2473281A1 Irak-m is a negative regulator of toll-like receptor signaling |
| 07/24/2003 | CA2473229A1 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | CA2473108A1 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 07/24/2003 | CA2472579A1 Hiv vaccine and method of use |
| 07/24/2003 | CA2472472A1 Treatment of bone disorders with skeletal anabolic drugs |
| 07/24/2003 | CA2472381A1 Glycosyltransferase gnt-v having neovascularization action |
| 07/24/2003 | CA2472203A1 The use of il6r/il6 chimera in nerve cell regeneration |
| 07/24/2003 | CA2472160A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/24/2003 | CA2471907A1 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/24/2003 | CA2471891A1 Methods of inducing or enhancing connective tissue repair |
| 07/24/2003 | CA2471744A1 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | CA2471513A1 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | CA2471483A1 Polytartrate composition |
| 07/24/2003 | CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | CA2471363A1 Albumin fusion proteins |
| 07/24/2003 | CA2471192A1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/24/2003 | CA2470998A1 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/24/2003 | CA2470571A1 Povidone-containing carriers for polypeptide growth factors |
| 07/24/2003 | CA2470503A1 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/24/2003 | CA2470430A1 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | CA2470400A1 Cultured and encapsulated pancreatic stem cells |
| 07/24/2003 | CA2470359A1 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | CA2468610A1 Method for reducing morbidity and mortality in critically ill patients |
| 07/24/2003 | CA2463008A1 Efficient protein expression system |
| 07/23/2003 | EP1329511A1 Polypeptide having phospholipase a2 actiivty |